BEER-SHEVA, Israel and BINYAMINA, Israel, May 4, 2023 /PRNewswire/ — OncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, today announced that it has signed an option agreement with BGN Technologies, the technology transfer company of Ben-Gurion University of the Negev (BGU), to receive a license for a novel biosensing technology called IcAR (Immuno-checkpoint Artificial Reporter). IcAR was developed by a team of researchers from BGU.
Read more here.
![[Biolojic in Business Wire] First Patient Dosed in Phase 2 Portion of Aulos Bioscience’s Phase 1/2 Clinical Trial for AU-007, a Computationally Designed IL-2 Antibody for Solid Tumor Cancers](https://blog.ourcrowd.net/wp-content/themes/Extra/images/post-format-thumb-text.svg)
